1. All Products
  2. MEDROXYPROGESTERONE acetate, 150mg, 1ml, vial
Public Pricelist

MEDROXYPROGESTERONE acetate, 150mg, 1ml, vial

https://medicalguidelines.msf.org/en/node/865
https://unicat.msf.org/cat/product/11740
STD DINJMEDR1V-

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
22.1.2 - Injectable hormonal contraceptives
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
G03AC06
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

MEDROXYPROGESTERONE 150mg

Full Name

Synonym: depot medroxyprogesterone acetate (DMPA) or Depo-Provera®

Therapeutic Action

Long-acting synthetic progestogen

Indications

Long-acting female contraception (3 months)

Long-term treatment of functional uterine bleeding

Instructions for use

Must be given as deep IM injection every 3 months.

Shake the vial well before administration to make the injectable suspension homogeneous.

    Precautions for Use

    Contraindicated during pregnancy.

    Storage

    • Below 25ºC
    • Do not refrigerate. Do not freeze.